SV2016005282A - NEW COMPOUNDS - Google Patents
NEW COMPOUNDSInfo
- Publication number
- SV2016005282A SV2016005282A SV2016005282A SV2016005282A SV2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A
- Authority
- SV
- El Salvador
- Prior art keywords
- compounds
- new compounds
- enbossing
- pharmaceutics
- inhibitors
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A INHIBIDORES DE LAS VÍAS DE SEÑALIZACIÓN DE WNT DE LA FÓRMULA GENERAL (I) COMO SE DESCRIBE Y SE DEFINE EN LA PRESENTE, A MÉTODOS DE PREPARACIÓN DE DICHOS COMPUESTOS, A COMPUESTOS INTERMEDIARIOS ÚTILES PARA PREPARAR DICHOS COMPUESTOS, A COMPOSICIONES FARMACÉUTICAS Y COMBINACIONES QUE COMPRENDEN DICHOS COMPUESTOS Y AL USO DE DICHOS COMPUESTOS PARA PRODUCIR UNA COMPOSICIÓN FARMACÉUTICA PARA EL TRATAMIENTO O LA PREVENCIÓN DE UNA ENFERMEDAD, EN PARTICULAR DE UN TRASTORNO HIPERPROLIFERATIVO, COMO UN ÚNICO AGENTE O EN COMBINACIÓN CON OTROS INGREDIENTES ACTIVOSTHE PRESENT INVENTION REFERS TO INHIBITORS OF THE WNT SIGNALING ROUTES OF THE GENERAL FORMULA (I) AS DESCRIBED AND DEFINED HEREIN, TO PREPARATION METHODS OF SUCH COMPOUNDS, TO INTERMEDIARY COMPOUNDS TO PREPARE THESE COMPOUNDS, PHARMACEUTICS AND COMBINATIONS THAT INCLUDE SUCH COMPOUNDS AND THE USE OF SUCH COMPOUNDS TO PRODUCE A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF A DISEASE, IN PARTICULAR OF A HYPERPROLIFERATIVE DISORDER, AS A UNIQUE ENBOSSING
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461968172P | 2014-03-20 | 2014-03-20 | |
| EP14185274 | 2014-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2016005282A true SV2016005282A (en) | 2018-12-05 |
Family
ID=65628886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2016005282A SV2016005282A (en) | 2014-03-20 | 2016-09-20 | NEW COMPOUNDS |
Country Status (5)
| Country | Link |
|---|---|
| CL (1) | CL2016002368A1 (en) |
| IL (1) | IL247327A0 (en) |
| MA (1) | MA39762A (en) |
| SV (1) | SV2016005282A (en) |
| ZA (1) | ZA201605726B (en) |
-
2015
- 2015-03-18 MA MA039762A patent/MA39762A/en unknown
-
2016
- 2016-08-17 ZA ZA201605726A patent/ZA201605726B/en unknown
- 2016-08-17 IL IL247327A patent/IL247327A0/en unknown
- 2016-09-20 CL CL2016002368A patent/CL2016002368A1/en unknown
- 2016-09-20 SV SV2016005282A patent/SV2016005282A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2016002368A1 (en) | 2017-03-03 |
| IL247327A0 (en) | 2016-09-29 |
| ZA201605726B (en) | 2019-11-27 |
| MA39762A (en) | 2017-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017001204A1 (en) | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors | |
| EA201691582A1 (en) | NEW PHARMACEUTICAL PREPARATIONS | |
| EA201692301A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
| NI201600144A (en) | QUINOXALINE DERIVATIVES USEFUL AS MODULATORS OF FGFR KINASE | |
| DOP2016000253A (en) | NEW COMPOUNDS | |
| MX382671B (en) | COMPOUNDS FOR USE IN THE TREATMENT OR AMENDING OF HUNTINGTON'S DISEASE | |
| MX2020011104A (en) | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE. | |
| EA201691988A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
| EA201790273A1 (en) | FLAGELLIN COMPOSITIONS AND THEIR APPLICATION | |
| CL2017001046A1 (en) | Bromodomain Inhibitors | |
| CL2016002072A1 (en) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease | |
| EA201591728A1 (en) | HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION | |
| EA201691216A1 (en) | COMPOUNDS OF LINACLOTIDE WITH Slow Release | |
| MX2016010216A (en) | Solid pharmaceutical compositions of androgen receptor antagonists. | |
| MX387235B (en) | PYRAZOLOPYRIDINE DERIVATIVES AND THEIR USE IN THERAPY | |
| EA201500801A1 (en) | BENZOHINOLONE INHIBITORS VMAT2 | |
| GT201500247A (en) | IMIDAZOPIRIDAZINAS REPLACED | |
| CL2016003074A1 (en) | Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer. | |
| ECSP16008797A (en) | DERIVATIVES OF HETEROBICICLOARIL AS RORC2 INHIBITORS AND METHODS OF USE OF THE SAME | |
| DOP2016000212A (en) | CONDENSED HETEROCICLES REPLACED AS MODULATORS OF GPR119 FOR THE TREATMENT OF DIABETES, OBESITY, DISLIPIDEMIA AND RELATED DISORDERS | |
| SV2017005412A (en) | COMPOUNDS OF 1-RENT-6-OXO-1,6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME | |
| EA201690783A1 (en) | SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES | |
| DOP2016000297A (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES | |
| MX2016012784A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions. | |
| CL2016000038A1 (en) | Pyroxolo-substituted pyridinamines |